MDVX

 
Common Stock SEC Reporting - Current
OTCQB
Verified Company Profile 11/15/2017
Contact Info
  • 3060 Royal Boulevard S.
  • Ste 150
  • Alpharetta, GA 30022

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Sep 30, 2017 10-Q
CIK 0001591165
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 3841 - Surgical and medical instruments
Incorporated In: NV, USA
Year of Inc. 2013
Employees 18 a/o Sep 30, 2017
Company Officers/Contacts
Jarret S. Gorlin CEO
Patrick Kullman COO
Charles Farrahar CFO
Jeff Wright Controller
Jason Assad IR
Company Directors
Jesse Crowne Co-Chairman
W. Larry Papasan Co-Chairman
James R. Andrews
Randal R. Betz
Jarret S. Gorlin
Scott M. W. Haufe
Cyde A. Hennies
James Ron Lawson
Jon Mogford
John C. Thomas,Jr.
Service Providers
Accounting/Auditing Firm
Frazier & Deeter, LLC
1230 Peach Street, N.E.
Suite 1500
Atlanta, GA, 30309
United States

Legal Counsel
Sichenzia Ross Ference Kesner LLP
1185 Avenue of the Americas
37th Floor
New York, NY, 10036
United States

Investor Relations Firm
Not Available
MDVX Security Details Other Company Securities
Share Structure
Market Value1 $14,145,719 a/o Dec 15, 2017
Authorized Shares 90,000,000 a/o Sep 30, 2017
Outstanding Shares 21,113,013 a/o Nov 15, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value Not Available
Transfer Agent(s)
Shareholders
Shareholders of Record 227 a/o Nov 15, 2017
Short Selling Data
Short Interest (%)
Significant Failures to Deliver No

1Market Value calculated only for respective security